|
🐜
|
Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents
14 auth.
A. Robertson,
M. Majchrzak,
Courtney M. Smith,
R. Gagnon,
N. Devidze,
G. Banks,
Sean C. Little,
Fizal Nabbie,
D. Bounous,
Janet Dipiero,
...
L. Jacobsen,
L. Bristow,
M. Ahlijanian,
S. Stimpson
|
4 |
2017 |
4
🐜
|
|
🐜
|
NaV channel variants in patients with painful and nonpainful peripheral neuropathy
35 auth.
Samir Wadhawan,
S. Pant,
R. Golhar,
S. Kirov,
John Thompson,
L. Jacobsen,
I. Qureshi,
S. Ajroud-Driss,
R. Freeman,
D. Simpson,
A. Smith,
A. Hoke,
L. Bristow,
P. Shlemon,
Marlene Dodinval,
...
J. Robinson-Papp,
Alexandra Nmashie,
Sandeep K. Sharma,
M. George,
Simone Thomas,
D. Cornblath,
C. Sumner,
B. Morrison,
H. Ilieva,
L. Ostrow,
M. Polydefkis,
Mohamed Khoshnoodi,
C. Gibbons,
John-Michael Li,
D. Menichella,
Jeffrey Allen,
Patricia Casey,
S. Mukit,
Benjamin C. Joslin,
J. Singleton
|
4 |
2017 |
4
🐜
|
|
🐜
|
A Phase 1b/2 Study of the Anti-Myostatin Adnectin RG6206 (BMS-986089) in Ambulatory Boys with Duchenne Muscular Dystrophy: A 72-Week Treatment Update (P1.6-062)
16 auth.
K. Wagner,
B. Wong,
B. Byrne,
Cuixia Tian,
L. Jacobsen,
G. Tirucherai,
M. Rabbia,
H. Kletzl,
J. Dukart,
R. Ong,
...
Karl Yen,
G. Sajeev,
J. Signorovitch,
S. Ward,
C. Bechtold,
M. Krishnan
|
2 |
2019 |
2
🐜
|
|
🐬
|
LC-MS/MS assays to quantify sulfatides and lysosulfatide in cerebrospinal fluid of metachromatic leukodystrophy patients.
K. Cao,
Guodong Zhang,
L. Jacobsen,
Jiang Wu
|
2 |
2020 |
2
🐬
|
|
🦁
|
P.15 BMS-986089: A novel adnectin protein that dose dependently lowers free myostatin and increases muscle volume and lean body mass
L. Jacobsen,
C. Bechtold,
G. Tirucherai,
M. Ahlijanian,
F. Luo
|
1 |
2016 |
1
🦁
|
|
🐜
|
FP.19 Quantification of glycogen distribution in late-onset Pompe patients using 7 Tesla C13 NMR spectroscopy
7 auth.
G. Beha,
M. Stemmerik,
V. Boer,
A. Marsman,
L. Jacobsen,
E. Petersen,
...
J. Vissing
|
1 |
2022 |
1
🐜
|
